Team EORTC active in benefits for patients with cancer
24 Oct 2014
The EORTC is recognized worldwide for the exceptional work it does in the realm of cancer clinical research leading to improved treatments for patients with cancer, and EORTC Headquarters Staff are, indeed, deeply committed to that mission. So much so, that a number of EORTC Staff have recently combined their professional commitment to improve cancer treatments with their passion for running and have formed Team EORTC, a group that participates in various cancer benefit runs. For members of Team EORTC, quality of life is not just an aspect of clinical trials, it’s something to live by.
September 14, 2014 marked the 6th edition of La Bruxelloise – Urban Woman Jogging, an event organized to support breast cancer research. The event was held at Place Flagey in Brussels, and more than 2200 joggers ran 3, 6 or 9 km. Specifically designed for urban women joggers, men, dressed as women, were also encouraged to join the fun. On this occasion, Team EORTC electrified the crowd by running in the spirit of fun and camaraderie. Participants included Claire Gandilhon, Gladdys Arias, Carmela Caballero, Sandra Collette, Edit Szepessy, Caroline Gilotay and two courageous men: Vincent Smeets and Efstathios Zikos. Friends and family members joined Team EORTC making the run truly enjoyable.
On the heels of this successful event, additional EORTC staff joined Team EORTC to participate in the Belfius Brussels Marathon on 5 October 2014. Although this event presented a more challenging course, Team EORTC’s Gaetan de Shaetzen was able to complete the full marathon, Denis Lacombe, and Seraphine Rossi the half-marathon, and Bernard Kamp, Britt De Jongh, Carmela Caballero, Caroline Gilotay, Claire Gandilhon, Edit Szepessy, Edwin Nys, Elisa Rizzo, Emad Shash, Julie Coupain, Nicolas Dif, Sandra Collette, Stéphanie Kromar, Steven Deleu, and Thomas Valkaert the mini-marathon.
Team EORTC points out that exercise is one of twelve ways to reduce your cancer risk as listed in the European Code Against Cancer, and so you can count on seeing Team EORTC continue their efforts by participating in future events.
John Bean, PhD
EORTC, Medical Science Writer
Related News
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
